Literature DB >> 21979470

Faecal occult blood screening: knowledge, attitudes, and practice in four Hong Kong primary care clinics.

Tammy K W Tam1, K K Ng, C M Lau, T C Lai, W Y Lai, Luke C Y Tsang.   

Abstract

OBJECTIVES. To assess primary care patients for their awareness, knowledge, and attitude towards colorectal cancer and screening, to report on the uptake of faecal occult blood test screening and the results of screening, and explore predictors of screening uptake. DESIGN. Cross-sectional study. SETTING. Four primary care clinics in Hong Kong. PATIENTS. A total of 1664 patients aged 50 to 74 years attending the clinics in the period July 2006 to July 2007. MAIN OUTCOME MEASURES. Percentage of subjects who were aware that colorectal cancer is common and curable at an early stage, and who knew that faecal occult blood test or colonoscopy is useful for screening; relevant knowledge score; uptake rate of faecal occult blood testing; rate of testing positive; and factors predicting uptake. RESULTS. A total of 1645 questionnaires were collected. In all, 89% (95% confidence interval, 88-91%) were aware that colorectal cancer is common, 95% (94-96%) believed faecal occult blood test and colonoscopy are useful for screening, and 58% (56-61%) achieved a knowledge score of 50% or above. The uptake rate of the faecal occult blood test was 35%. Uptake was higher among those with a positive family history (odds ratio=1.57; 95% confidence interval, 1.08-2.27; P=0.02), those who were more aware that colorectal cancer is common (1.86; 1.29-2.69; P=0.001), and that colorectal cancer is potentially curable at an early stage (1.76; 1.32-2.36; P=0.0001). Rate of testing positive was 2.1% (95% confidence interval, 0.9-3.3%); no colorectal cancer was detected and the neoplasia detection rate (for cancers and adenomas) was 5.1 per 1000 subjects screened. CONCLUSIONS. Patients were aware that colorectal cancer is common in our community, and faecal occult blood test or colonoscopy is useful for screening. The uptake of screening was low, though relatively higher for those with a positive family history and greater awareness of the high frequency and potential for cure of colorectal cancer. Faecal occult blood test positivity rate was 2.1%, and neoplasia detection rate 5.1 per 1000 screened.

Entities:  

Mesh:

Year:  2011        PMID: 21979470

Source DB:  PubMed          Journal:  Hong Kong Med J        ISSN: 1024-2708            Impact factor:   2.227


  6 in total

1.  Evaluation of the Knowledge Levels of 50-Year-Old and Older Individuals Regarding Colorectal Cancer.

Authors:  Ebru Turhan
Journal:  J Cancer Educ       Date:  2017-09       Impact factor: 2.037

2.  The prevalence and factors for cancer screening behavior among people with severe mental illness in Hong Kong.

Authors:  Phoenix Kit Han Mo; Winnie Wing Sze Mak; Eddie Siu Kwan Chong; Hanyang Shen; Rebecca Yuen Man Cheung
Journal:  PLoS One       Date:  2014-09-30       Impact factor: 3.240

3.  MicroRNA-20a in human faeces as a non-invasive biomarker for colorectal cancer.

Authors:  Tung On Yau; Chung Wah Wu; Ceen-Ming Tang; Yingxuan Chen; Jingyuan Fang; Yujuan Dong; Qiaoyi Liang; Simon Siu Man Ng; Francis Ka Leung Chan; Joseph Jao Yiu Sung; Jun Yu
Journal:  Oncotarget       Date:  2016-01-12

4.  The expression and significance of feces cyclooxygensae-2 mRNA in colorectal cancer and colorectal adenomas.

Authors:  Xiaofeng Li; Lixia Kong; Suhuan Liao; Jing Lu; Lin Ma; Xiaohua Long
Journal:  Saudi J Gastroenterol       Date:  2017 Jan-Feb       Impact factor: 2.485

5.  Factors Associated with Knowledge, Attitudes, and Practice towards Colorectal Cancer and Its Screening among People Aged 50-75 Years.

Authors:  Florence M F Wong
Journal:  Int J Environ Res Public Health       Date:  2021-04-13       Impact factor: 3.390

6.  The knowledge of colorectal cancer symptoms and risk factors among 10,078 screening participants: are high risk individuals more knowledgeable?

Authors:  Martin C S Wong; Hoyee W Hirai; Arthur K C Luk; Thomas Y T Lam; Jessica Y L Ching; Sian M Griffiths; Francis K L Chan; Joseph J Y Sung
Journal:  PLoS One       Date:  2013-04-03       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.